0001562180-23-004632.txt : 20230531 0001562180-23-004632.hdr.sgml : 20230531 20230531172224 ACCESSION NUMBER: 0001562180-23-004632 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230530 FILED AS OF DATE: 20230531 DATE AS OF CHANGE: 20230531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liu Ye CENTRAL INDEX KEY: 0001840407 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51122 FILM NUMBER: 23982119 MAIL ADDRESS: STREET 1: ROOM 502-I, WANT WANT PLAZA STREET 2: NO. 211 SHIMEN YI ROAD CITY: SHANGHAI STATE: F4 ZIP: 200041 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001314102 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 262774444 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-5000 MAIL ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: pSivida Corp. DATE OF NAME CHANGE: 20080619 FORMER COMPANY: FORMER CONFORMED NAME: pSivida LTD DATE OF NAME CHANGE: 20050111 4 1 primarydocument.xml PRIMARY DOCUMENT X0407 4 2023-05-30 false 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001840407 Liu Ye 56F, ONE MUSEUM PLACE, 669 XIN ZHA ROAD JING'AN DISTRICT SHANGHAI 200041 true false false false false Common Stock, $0.001 par value 2023-05-30 4 S false 1.00 6.00 D 3010721.00 I Ocumension Therapeutics Sale of one share to test new broker The shares are held by Ocumension Therapeutics. The reporting person is Chief Executive Officer and a Director of Ocumension Therapeutics. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. /s/ Ron Honig, Attorney-in-Fact 2023-05-31